Therapeutic benefits of methylene blue on cognitive impairment during chronic cerebral hypoperfusion (2014)

Peer-Reviewed Study · Auchter A, Williams J, Barksdale B, Monfils MH, Gonzalez-Lima F · 2014

Auchter A et al., 2014: Rat study of chronic cerebral hypoperfusion (permanent bilateral carotid occlusion) treated with daily 4 mg/kg USP methylene blue for one month, reporting that methylene blue attenuated the visual learning and memory deficits the occlusion caused.

We treated rats that underwent permanent bilateral carotid occlusion (2VO) or sham surgery with daily 4 mg/kg USP MB or saline for one month.

abstract

Auchter A et al., 2014: Rat study of chronic cerebral hypoperfusion (permanent bilateral carotid occlusion) treated with daily 4 mg/kg USP methylene blue for one month, reporting that methylene blue attenuated the visual learning and memory deficits the occlusion caused. Study type: animal (rat) surgical model with behavioural battery and metabolic mapping. N not stated in abstract. Country: USA. Dose/route/schedule: 4 mg/kg USP methylene blue daily for one month; route not stated in abstract (companion 2020 paper uses injections). Comparator: saline-treated 2VO and sham groups. Funder/conflicts: not stated in abstract. Study type: animal.